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Abstract
SUMMARY
Asthma, allergic rhinitis (AR) and atopic dermatitis also called eczema are allergic co-morbidites which are likely to depend on pleiotropic
genetic effects as well as on specific genetic factors. After a previous genome-wide linkage screen conducted for asthma and AR in a
sample of 295 French EGEA families ascertained through asthmatic subjects, the aim here was to search for genetic factors involved in
eczema and more particularly those ones shared by the three allergic diseases using the same EGEA data. In this sake, eczema and
phenotypes of allergic disease  accounting for the joint information on the presence/absence of the three diseases were examined by‘ ’
linkage analyses using the Maximum Likelihood Binomial (MLB) method. A fine mapping was carried out in regions detected for
potential linkage, followed by association studies using the Family Based Association Test (FBAT). Evidence for linkage to 11p14 region
was shown for allergic disease  and eczema. Linkage was also indicated between eczema and 5q13 and between allergic disease  and both‘ ’ ‘ ’
5p15 and 17q21 regions. Fine mapping supported the evidence of linkage to 11p14 and FBAT analyses showed association between ‘
allergic disease  and a marker located at the linkage peak on 11p14. Further investigations in this region will allow identifying genetic’
factor(s) which could have pleiotropic effect in the three allergic diseases.
MESH Keywords             Adolescent ; Adult ; Child ; Chromosomes ; Human ; Pair 11 ; Eczema ; genetics ; Female ; Genetic Markers ; Genetic Screening ; Humans ; 
      Hypersensitivity ; genetics ; Linkage (Genetics) ; Lod Score ; Male ; Nuclear Family ; Questionnaires
Author Keywords     atopic dermatitis ; linkage analysis ; genome screen ; fine mapping ; association study
Introduction
Pleiotropy is likely to play an important role in the genetic determinism of multifactorial diseases as shown by genome-wide linkage
screens ( ; ; ) and recently genome-wide association studies of complex disorders (Kullo et al. 2005 Marlow et al. 2003 Williams et al. 1999 the
). Asthma, allergic rhinitis (AR) and atopic dermatitis (AD) also called eczema, are allergic co-morbidites which may shareWTCCC, 2007
genetic determinants as suggested by their strong associations at both the individual and familial levels ( ). Genes withDold et al. 1992
pleiotropic effects underlying these three diseases, may be involved in allergic processes or in the barrier mechanisms of the epithelium (of
either the skin, the nose or the lung). However there may also be genes specific to two of the three diseases, e.g. specific to the airway organs as
nose and lung, or specific to each of the three diseases.
Few genome-wide searches have been conducted for AR ( ; , ; )Haagerup et al. 2001 Yokouchi et al. 2002 Dizier et al. 2005 Bu et al. 2005
and AD ( ; ; ; ) contrasting with the numerous genome screensLee et al. 2000 Cookson et al. 2001 Bradley et al. 2002 Haagerup et al. 2004
performed for asthma and asthma-associated phenotypes ( ; ). These scans have revealed aWills-Karp and Ewart 2004 Bouzigon et al. 2005
small number of regions potentially linked to 2 or 3 of those diseases, but none of them as yet examined jointly these diseases. Candidate gene
studies have reported a few genes associated with at least two of theses diseases including genes involved in the allergic response such as TLR2
(4q31.3) ( ), IL-13 (5q31) ( ; ; ), FCER1B (11q12) (Ahmad-Nejad et al. 2004 Tsunemi et al. 2002 He et al. 2003 Liu et al. 2000 Folster-Holst et al.
; ), TGFB1 (19q13) ( ) and CCL5 (17q11) ( ), indicating pleitropic effect of these1998 Cox et al. 1998 Arkwright et al. 2001 Nickel et al. 2000
genes.
The EGEA study (Epidemiological study on the Genetics and Environment of Asthma) was designed to characterize genes and
environmental factors underlying asthma related phenotypes in families ascertained through asthmatic subjects. This study includes extensive
information on various biological and physiological phenotypes as well as asthma-associated diseases as AR and eczema. Genome scans were
recently carried out in the 295 EGEA family sample for seven asthma/atopy associated phenotypes ( ) and for asthma andBouzigon et al. 2004
AR ( ). Joint analysis of asthma and AR showed strong evidence for a genetic component on the 1p31 region underlying theDizier et al. 2005
co-morbidity of asthma plus AR ( ). Our present aim was to complete these scans by searching for genetic regions linked toDizier et al. 2007
eczema and more precisely to characterize the regions shared by eczema and the two other allergic diseases, asthma and AR. For this purpose,
we considered an allergic disease  phenotype which was defined in two ways: 1/by the presence of at least one of the allergic diseases (asthma,‘ ’
AR and eczema), 2/using an ordered categorical trait varying from 0 to 3 depending on the number of allergic diseases presented by a subject.
The genome-wide linkage analyses for eczema and allergic disease  phenotypes were conducted in the sample of 295 EGEA families using the‘ ’
original panel of 378 microsatellites. In regions showing indication of linkage, we conducted fine mapping and association studies in the
vicinity of the linkage peaks. The present study is the first genome linkage scan examining jointly asthma, AR and eczema to search for
pleiotropic genes involved in these three diseases.
Material and Methods
Family data
The main EGEA sample included 348 nuclear families selected through one asthmatic proband. An additional sample of 40 nuclear
families was selected through two asthmatic sibs in order to increase the number of informative families for linkage analyses of asthma.
Inclusion criteria met by probands were described elsewhere ( ). The present scan was applied to 307 EGEA familiesKauffmann et al. 1999
having at least two sibs with DNA available ( ). After excluding families with insufficient DNA available or showingBouzigon et al. 2004
Non-Mendelian transmission, the analyzed sample included 295 families (n  1317 individuals). Ethical committee of the hospital group = ‘
Cochin Saint Vincent de Paul-Sainte Anne  approved the protocol and subjects signed informed consent forms.’
Phenotypes analyzed
Information on respiratory and allergic symptoms, medical history and environmental factors was collected using a standardized
questionnaire ( ). Various physiological tests were performed, which have been already described (Kauffmann et al. 2002 Kauffmann et al. 1999
) and included bronchial responsiveness and skin prick tests to common aeroallergens. Eczema was defined by answers to a questionnaire in
adults and children. For children, the questions asked to the child s mother (or father) were: 1a/Have your child had eczema before two years of’
age? 2a/After two years of age? and for adults: 1b/Have you had eczema during childhood? The precise time of eczema onset (before/after 2
years of age) was not asked to adults in order to avoid a large proportion of wrong or missing responses.
Two definitions of eczema were possible: 1) a positive response to 1a for children and to 1b for adults, 2) a positive response to 1a or 2a for
children and to 1b for adults. We only used here the second definition since it has the advantage to be homogenous in children and adults. The
high frequency of atopy defined by a positive skin test response to at least one allergen in both children and adults reporting eczema
strengthened the validity of our eczema definition Definitions of asthma and AR used in linkage analyses of the allergic disease  phenotype‘ ’
have been previously described (  ). Asthma (AST) was defined using the following criteria: a positive response to atDizier et al. 2005 , 2007
least one of the two questions (1/Have you ever had attacks of breathlessness at rest with wheezing? 2/Have you ever had an asthma attack?),
associated with either the presence of BHR (defined as a fall in baseline FEV , the forced expiratory volume at one second, 20  at 4mg/ml1 %
methacholine), an increase of baseline FEV  12  after bronchodilator use, hospitalization for asthma in life or asthma therapy. The AR trait1 %
was defined by the presence of at least one of the following symptoms: sneezing or runny nose to hay/flower or animals or dust.
The allergic disease  phenotype was defined in two ways 1/by the presence of at least one of the 3 allergic diseases (ECZ AST AR), and‘ ’ ± ±
that, whatever the disease(s) was, 2/using an ordered categorical trait varying from 0 to 3 depending on the number of allergic diseases
presented by a subject.
Genotypes
A total of 1317 subjects were genotyped with a panel of 396 microsatellites (378 autosomal markers). The genotyping protocol was
described elsewhere ( ; ). The Linkage Marker Set MD 10 (Applied Biosystems, Foster City, CA, USA)Bouzigon et al. 2004 Dizier et al. 2005
formed the core marker set for the genome-wide screen. The microsatellite markers, labelled with fluorescent dyes (FAM , HEX , NED ),™ ™ ™
are distributed at an average marker density of 10 centimorgan (cM roughly every 10 million bases in the genome) and have an average
heterozygosity of 75 .%
Before statistical analysis, rigorous genotype quality assurance was performed to ensure accurate binding of alleles. In the four regions
detected potentially linked to eczema and/or to the allergic disease  phenotype (s), fine mapping was carried out by genotyping additional‘ ’
markers in an interval spanning about 10 cM on each side of the linkage peaks: 2 markers on 5p15, 3 markers on 5q13, 8 markers on
11p14-q13 and 4 markers on 17q21.
Consistency of the data with Mendelian inheritance and presence of double recombination between loci was evaluated using Pedcheck (O’
) and Mendel ( ). Hardy-Weinberg equilibrium was also checked for all markers.Connell and Weeks 1998 Lange et al. 2001
Linkage analysis methods
Linkage analyses were performed by a model-free approach, the Maximum Likelihood Binomial (MLB) method which is likelihood-based
and can be applied to the whole sibship of affected subjects ( ; ; ). In brief, theMajumder and Pal 1987 Satsangi et al. 1996 Abel et al. 1998
principle of this method is based on the binomial distribution of the number of affected sibs receiving a given parental allele from heterozygous
parents. The probability  for an affected sib to receive from his/her parent the marker allele transmitted with the disease allele is equal to 0.5α
under the null hypothesis of no linkage and  is greater than 0.5 under the hypothesis of linkage. Test for linkage was performed using aα
likelihood ratio test statistic, 2Ln L()/L(  2 0.5)  with the statistic being distributed asymptotically as a mixture distribution of 0.5  0df and= [ α = ] 2
0.5  . The test can also be expressed either as a one-sided standard normal deviate denoted as Z   or as a lod score criterion, lod MLB2 1df MLB= ½ =
/(2Ln(10)). This method has been extended to categorical traits by introducing a latent binary variable (Y 0;1 ) which captures the linkage={ }
information between the observed categorical phenotype (Z) and the marker (M). This method requires to assign the probability of the latent
variable (i.e. being affected or not) according to each observed category of the phenotype. The likelihood of the observations is then written by
use of binomial distributions of parental marker alleles among offspring according to the value of the unobserved binary variable. Multipoint
linkage analyses of binary and polychotomous phenotypes were conducted with MLBGH ( ) which incorporatesAbel and M ller-Myshok 1998ü
the MLB method into the multipoint approach of Genehunter ( ).Kruglyak et al. 1996
Family based association test
Association studies were performed using the FBAT method ( ), which is based on the following score S  for n  offspringHorvath  2001et al. i i
in the ith family: S    X T , where T  is a function of jth offspring phenotype and X  a function of jth offspring genotype in family i.i = Σj 1, ni= ij ij ij ij
The standard choice, as classically used by the TDT ( ), is to let T 1 for affecteds and T 0 for unaffecteds and X  beSpielman et Ewens, 1998 ij= ij= ij
the number of A alleles (additive coding). We used the standard coding for T  and both the multi-allelic and additive codings for X . Whenij ij
considering the additive coding (i.e. testing alternatively one allele against all other 2 ones), S-E(S) /Var(S) follows a  with 1 degree of[ ] χ2
freedom while for the multi-allelic scoding, the statistic (S-E(S)) Var(S)  (S-E(S)) has an approximate  distribution with degrees of freedom’ 1− χ2
equal to the number of alleles minus one. This method was applied to test association in presence of linkage. We also used the approach using
the empirical variance-covariance estimator which is robust to the correlation among sibling marker genotypes ( ). TheLake et al. 2000
Family-Based Association Test was conducted for all genotyped microsatellites in all regions detected by the MLB approach.
Results
Distribution of eczema
Among the 726 genotyped siblings of the 295 EGEA families selected through one asthmatic subject, frequencies of sibs with eczema and ‘
allergic disease  (ECZ  AST  AR) were respectively equal to 33  and 72  ( ). These frequencies did not differ according to gender’ ± ± % % Table 1
for eczema (p 0.77) but were significantly higher in males than in females for allergic disease  (p 0.01). Mean ages among siblings with= ‘ ’ =
eczema and with allergic disease  were 14.3 and 15.8 years respectively. The proportion of sibs with asthma and AR among those having‘ ’
eczema and the distribution of asthma, eczema and AR among sibs with allergic disease  are also given in . We also examined  of‘ ’ Table 1 %
atopy or SPT (defined by a positive skin test response to at least one allergen) in siblings with eczema and allergic disease . Frequencies of‘ ’
asthma, AR and SPT among sibs with eczema were respectively equal to 71 , 52  and 77 . Among siblings having allergic disease ,% % % ‘ ’
frequencies of eczema, asthma, AR and SPT were equal respectively to 46 , 77 , 62  and 78 . The proportion of siblings with allergic% % % % ‘
disease  having all three diseases (ECZ AST AR) is as high as 20 , demonstrating the strong relationship among these diseases. However,’ + + %
these frequencies may be partly explained by the ascertainment of our sample through asthmatic subjects. Considering the allergic disease‘ ’
phenotype defined by the ordered categorical trait, the numbers of siblings with (0, 1, 2 or 3) disease(s) were (207, 197, 218 or 104). The
distributions of the 295 EGEA families according to the number of genotyped sibs available for linkage analysis of eczema and allergic disease‘
 phenotypes are shown in . To provide a summary indicator of the amount of information available for analysis, the numbers of’ Table 2
independent sib-pairs computed from sibship sizes (a sibship of size n corresponds to (n 1) independent sib-pairs) are also given in .− Table 2
Linkage analysis
Linkage peaks (expressed in terms of LOD-MLB scores) detected at p  0.005 are presented in  (eczema) and 4 (ECZ  AST ≤ tables 3 ± ±
AR). LOD-MLB curves for chromosomes harbouring these peaks are shown in  (eczema) and 2 (ECZ  AST  AR). The InformationFigures 1 ± ±
Content (IC), which measures the informativity of the data for linkage analysis, was also given at each marker position on these figures. For
eczema, one region, 5q13, showed a linkage peak with p 0.002 and another one, 11p14, contained a peak with p 0.0007.= =
Interestingly, the allergic disease  phenotype (ECZ  AST  AR) was also found to be linked to the 11p14 region (p 0.0005). Two other‘ ’ ± ± =
regions were revealed: 5p15 (p  0.002) and 17q21 (p 0.003). When analyzing the allergic disease  phenotype defined by the ordered= = ‘ ’
categorical trait, a linkage peak was also detected in the 11p14 region, but with a smaller intensity (p 0.01). No other region was detected=
(results not shown).
As shown in , fine mapping, conducted in the two regions potentially linked to eczema, led to an increase in evidence of linkage forfigure 1
eczema on both 5q13 (p  0.0007) and 11p14 (p 0.00005). However, the fine mapping did not change much the linkage results on 5p15,= =
11p14 and 17q21 for the allergic disease  phenotype (ECZ  AST  AR) ( ).‘ ’ ± ± table 4
Family-based association analyses
FBAT analysis did not indicate any linkage/association to eczema (i.e. no result leading to a p value  0.005) in any region detected by the≤
MLB method. In contrast, evidence for linkage and association was found between allergic disease  (ECZ  AST  AR) and D11S4152 marker‘ ’ ± ±
located on 11p14 region (p 0.004 and 0.05 using FBAT without and with the empirical variance/covariance estimator respectively) at the same=
position as the MLB linkage peak.
Discussion
The present genome-wide scan is the first one searching the existence of genetic determinants predisposing to any of the three diseases,
asthma, AR and eczema. It also allowed making comparisons of the linkage signals detected here for eczema to those previously reported for
asthma and AR in the same families ( ). Concerning eczema, there is a strong linkage signal with the 11p14 region. EvidenceDizier et al. 2005
for linkage to this region was further supported by the fine mapping with an improvement of the linkage signal (p-value decreasing from p=
0.0007 to 5.10 ). Indication of linkage is also showed for another region 5q13. While 5q13 was not previously detected for asthma or AR in5−
the EGEA study, there was in the 11p14 region a small linkage signal for the two diseases. No linkage signal was detected for eczema to
regions reported in our previous scans conducted for AR and/or asthma (1p31, 2q32, 3p24-p14, 9p22 and 9q22-q34) ( ). ADizier et al. 2005
strong linkage signal of the 11p14 region was also observed with the allergic disease  phenotype defined by the presence of at least one allergic‘ ’
disease. Moreover, an association found between this phenotype and a marker on 11p14 region, located at the linkage peak, strengthened this
linkage result. Two additional regions, 5p15 and 17q21, were also detected for linkage to allergic disease , but with a smaller intensity.‘ ’
None of the regions detected by the previous genome scans conducted for AD ( , , , Lee et al. 2000 Cookson et al. 2001 Bradley et al. 2002
) was found by the present analysis. However, reported results were already heterogeneous across the four previousHaagerup et al. 2004
published AD/eczema genome scans. Heterogeneity of results could be due to different modes of family ascertainment, phenotype definitions
and linkage analysis statistics. There was indeed heterogeneity regarding the mode of ascertainment, since eczema family samples in previous
scans were recruited through one or two affected siblings while the present sample consisted of families with at least two affected siblings,
selected from the primary sample of 295 EGEA families ascertained through asthmatic subjects. Interestingly, the Swedish and Danish studies (
; ) showing the most similar results (3p and 18q detected by both scans) used the most similarBradley et al. 2002 Haagerup et al. 2004
phenotype definitions (clinical characteristics associated with elevated specific IgE levels to at least one allergen). Note also, that we used,
here, responses to diagnosis questions on eczema and not presence of clinical symptoms or presence of atopy. However, most siblings with
eczema in our sample were atopic (77 ). We repeated linkage analyses by examining eczema associated with a positive skin test response to at%
least one allergen, as also recommended by the Nomenclature review committee of the World Allergy Organisation (2003) (Johansson et al.
). This did not lead to detect any of the regions found in the Swedish and Danish scans ( ; ), nor2004 Bradley et al. 2002 Haagerup et al. 2004
regions reported by any other scans (data not shown). However the 11p14 region was still detected although in a slightly lesser extent (p=
0.001), probably because of the important decrease in number of affected sibs. Some siblings may have been discarded since the tested
allergens did not include food allergens. It has indeed been shown that, early in life, eczema is marked by a much higher frequency of food
sensitization than aeroallergen sensitization ( ). Moreover, a transient form of eczema without any detectable IgEGuillet and Guillet 1992
sensitization has been described in children, which develop a sensitization to aeroallergens and to food allergens later in life (Novembre et al.
). We also repeated linkage analyses by considering as additional criterion for eczema, an age at onset before two years of age for the2001
children. That is considered as a good indicator of the presence of atopic eczema. This information being not available for adults, the criterion
was thus unchanged for adults, i.e. an onset during childhood. Theses analyses led to an evidence of linkage as strong as the one with the
eczema phenotype used here and allowed us to check our findings with the 11p14 region. One main topic of our study was to search for
pleiotropic effect between the allergic diseases. In this sake, we previously examined eczema associated with either asthma or AR (as already
done for asthma associated with AR), but there was no improvement of any linkage signal (result not shown). Moreover, it was not possible to
analyze the most stringent phenotype of eczema associated with both asthma and AR because of the too small number of affected sibs.
In the same spirit, we then examined the allergic disease  phenotypes. Linkage analysis of the allergic disease  phenotype defined by the‘ ’ ‘ ’
presence of any of the three diseases, revealed a strong linkage signal to 11p14. This latter result might be partly explained by the strong
evidence of linkage of this region to eczema and by the linkage signals to AR (p 0.01) and asthma (p 0.02). When using the other allergic= = ‘
disease  phenotype defined by an ordered categorical trait, a linkage signal although of small magnitude, was also found in the 11p14 region.’
These different results could suggest that a genetic factor in the 11p14 region is involved more likely in the presence/absence of the allergic
disease than in the intensity of the disease measured by the ordered categorical trait, i.e. the number of allergic disease(s) presented by the
subject. Finally the family sampling through asthmatic subjects might have affected the conclusions of our analyses by leading to detect
preferentially genes involved in both eczema and asthma (i.e. with pleiotropic effect). Indeed most sibpairs with eczema were also asthmatic.
That could explain why the 11p14 region was founded here linked to both eczema and allergic disease .‘ ’
Regions found in our study linked to eczema and/or to allergic disease  have been previously reported by EGEA scans for other‘ ’
phenotypes and/or by other genome scans for asthma and asthma-related phenotypes. The 5q13 region potentially linked here to eczema and to 
allergic disease , was reported by a Danish scan ( ) that showed a small linkage signal to AR. The 11p14 region detected‘ ’ Haagerup et al. 2001
here to be linked to eczema and allergic disease  was reported for atopy and asthma related phenotypes in some studies ( , ‘ ’ Wjst et al. 1999
, , , ). Note that there was no indication of linkage of this region,Altmuller et al. 2005 Ober et al. 2000 Postma et al. 2005 Ferreira et al. 2006
neither to IgE nor to SPT, but only an indication of linkage to AR and asthma in the whole EGEA sample ( ) and to IgE in aDizier et al. 2005
subset of families with at least 2 two asthmatic sibs ( ). The 17q21 region, found here potentially linked to allergic disease ,Dizier et al. 2000 ‘ ’
indicated linkage to atopy in the EGEA families ( ) and was reported linked to atopy and asthma-related phenotypes byBouzigon et al. 2004
other scans ( ; ). This region contains a few candidate genes shown to be associated to AD and which areCSGA 1997 Koppelmann et al. 2002
involved in the immune response as SCYA5 and RANTES ( ). Finally, the 5p15 region suggesting linkage to allergic diseaseNickel et al. 2000 ‘ ’
indicated linkage to atopy in EGEA families ( ), to BHR in the Hutterites ( ), to asthma in Afro-American Bouzigon et al. 2004 Ober et al. 2000
 and to AD in the Swedish families ( ).CSGA families (1997) Bradley et al. 2002
We chose here a quite stringent threshold (p 0.005) to select linked regions, because of the increase of type one error due to multiple
testing. As in the vast majority of published scans for asthma, none of our results reached the genome-wide significant level (p 2.10 )5−
proposed by ( ), although LOD scores in the 11p14 region reached the criterion of suggestive linkage (p 7.10 ) (Lander and Kruglyack 1995 4−
). Evidence for linkage to 11p14 was further supported by the fine mapping that led to a strong improvement of theLander and Kruglyack 1995
linkage signal (p-value decreasing from p  0.0007 to 5.10 ), the former signal being close to the genome-wide significant level (= 5− Lander and
).Kruglyack, 1995
In conclusion, evidence of linkage of 11p14 to eczema and allergic disease  was here well supported. Moreover, the association found‘ ’
between the allergic disease  phenotype and a marker located at the allergic disease  linkage peak in the 11p14 region, strengthened the linkage‘ ’ ‘ ’
results and suggested that a gene with a pleiotropic effect tightly linked to that peak, may be involved in the allergic diseases. However,
whether the 11p14 region contains one or more genetic factor(s) require further investigation. Association studies with SNPs covering this
region and with candidate genes involved in the allergic response and the skin inflammation response are currently being carried out which can
lead to identify the genetic factor(s) on 11p14.
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Figure 1
Curves of Lod MLB scores of eczema of genome scan (GS) and fine mapping (FM) for chromosomes with Lod MLB scores  1.5 in the 295≥
families.
Figure 2
Curves of Lod MLB scores of allergic disease  phenotype (ECZ  AST AR) of genome scan (GS) and fine mapping (FM) for chromosomes with‘ ’ ± ±
Lod MLB scores  1.5 in the 295 families.≥
Table 1
Distribution of the eczema and allergic disease  phenotype (ECZ  AST AR) in the 726 genotyped siblings of the 295 EGEA families‘ ’ ± ±
Frequency ( ) in%
All Male Female
Eczema 33 34 32
ECZ  AST AR± ± 72 76 67
Frequency ( ) of%
Eczema AST AR SPT
Among subjects:
Eczema 100 71 52 77
ECZ  AST AR± ± 46 77 62 78
Table 2
Distribution of families according to the number of genotyped sibs available for linkage analyses to eczema and allergic disease  phenotypes in the 295 families.‘ ’
Phenotypes 2 sibs 3 sibs 4 sibs 5 sibs total
Eczema 47 4 1 1 53 (62)
‘allergic disease  ECZ  AST AR ’ ± ± (1) 154 30 3 2 189(231)
‘allergic disease  Categorical trait ’ (2) 174 82 13 25 294 (477)
In parentheses are the corresponding numbers of affected sib-pairs.
 (1) allergic disease  phenotype defined by the presence of at least one the 3 allergic diseases (asthma, AR, eczema).‘ ’
 (2) allergic disease  phenotype defined by the ordered categorical trait varying from 0 to 3 depending on the number of allergic diseases presented by a subject.‘ ’
Table 3
Results of linkage analyses of eczema in the 295 families using the MLB method
Marker Position  (cM)*
GS GS FM+
D5S2003 78 2.2 ( )0. 0007
D5S424 82 1.9 ( )0.002 1.9 ( )0.001
D5S672 86 1.1 ( )0.01
D11S915 31 2.6 ( )0.0003
D11S904 34 2.2 ( )0.0007 3.0 ( )0.0001
D11S4152 35 3.2 ( )0.00005
In black are the markers of the genome scan (GS) and the results of linkage (lod MLB and in parentheses, p values) using the multipoint information on the markers of the genome scan only.
In red are the markers of the fine mapping (FM) and the results of linkage (lod MLB and in parentheses, p values) using the multipoint information on markers of the genome scan plus the fine mapping.
 * the distance from pter retrieved from .http://www.marshmed.org/genetics
Table 4
Results of linkage analyses of the allergic disease  phenotype (ECZ  AST AR) in the 295 families using the MLB method‘ ’ ± ±
Marker Pos  cM ECZ  AST AR* ± ±
GS GS FM+
D5S1981 2 1.9 ( )0.002 1.8 ( )0.002
D5S417 7 0.8 ( )0.03
D11S915 31 2.1 ( )0.001
D11S904 34 2.3 ( )0.0005 2.3 ( )0.0005
D11S4152 35 2.3 ( )0.0005
D17S1868 64 1.6 ( )0.003 1.7 ( )0.003
D17S806 67 1.6 ( )0.003
D17S943 68 1.7 ( )0.003
In black are the markers of the genome scan and the results of linkage (lod MLB and in parentheses, p values) using the multipoint information on the markers of the genome scan only (GS).
In red are the markers of the fine mapping (FM) and the results of linkage (lod MLB and in parentheses, p values) using the multipoint information on markers of the genome scan plus the fine mapping (GS+
FM).
 * the distance from pter retrieved from .http://www.marshmed.org/genetics
